Eishi Miyazaki

2.2k total citations
100 papers, 1.6k citations indexed

About

Eishi Miyazaki is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Eishi Miyazaki has authored 100 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 41 papers in Physiology and 27 papers in Epidemiology. Recurrent topics in Eishi Miyazaki's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers), Asthma and respiratory diseases (21 papers) and Sarcoidosis and Beryllium Toxicity Research (19 papers). Eishi Miyazaki is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers), Asthma and respiratory diseases (21 papers) and Sarcoidosis and Beryllium Toxicity Research (19 papers). Eishi Miyazaki collaborates with scholars based in Japan, United States and Greece. Eishi Miyazaki's co-authors include Toshihide Kumamoto, Masaru Ando, Shin‐ichi Nureki, William R. Bishai, Tomiyasu Tsuda, Tetsujiro Fukami, Osamu Matsuno, Takuya Ueno, Emiko Ono and Richard E. Chaisson and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Bacteriology and CHEST Journal.

In The Last Decade

Eishi Miyazaki

96 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eishi Miyazaki Japan 25 666 573 354 279 267 100 1.6k
Keita Kasahara Japan 16 530 0.8× 418 0.7× 220 0.6× 137 0.5× 218 0.8× 35 1.6k
Nancy R. Slifman United States 11 201 0.3× 287 0.5× 274 0.8× 175 0.6× 160 0.6× 11 1.5k
Aarnoud Huissoon United Kingdom 27 239 0.4× 412 0.7× 249 0.7× 250 0.9× 298 1.1× 68 2.7k
Karoline I. Gaede Germany 18 462 0.7× 462 0.8× 176 0.5× 117 0.4× 258 1.0× 46 1.0k
Tina Hatley United States 4 295 0.4× 398 0.7× 227 0.6× 47 0.2× 365 1.4× 6 1.5k
Robert G. Horn United States 22 322 0.5× 175 0.3× 356 1.0× 382 1.4× 511 1.9× 41 2.2k
Björn R. Lúdvíksson Iceland 26 294 0.4× 254 0.4× 324 0.9× 112 0.4× 304 1.1× 62 2.6k
Shouming Qin China 15 633 1.0× 286 0.5× 302 0.9× 336 1.2× 129 0.5× 38 1.4k
Chi-Chang Shieh Taiwan 20 204 0.3× 166 0.3× 378 1.1× 329 1.2× 279 1.0× 47 1.5k
Shingo Maeda Japan 25 640 1.0× 131 0.2× 117 0.3× 112 0.4× 492 1.8× 120 1.7k

Countries citing papers authored by Eishi Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Eishi Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eishi Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eishi Miyazaki more than expected).

Fields of papers citing papers by Eishi Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eishi Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eishi Miyazaki. The network helps show where Eishi Miyazaki may publish in the future.

Co-authorship network of co-authors of Eishi Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Eishi Miyazaki. A scholar is included among the top collaborators of Eishi Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eishi Miyazaki. Eishi Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiota, Seiji, et al.. (2024). Lack of women physician representation in the Japanese Society of Hospital General Medicine. Journal of General and Family Medicine. 25(4). 187–192.
2.
Shiota, Seiji, et al.. (2023). A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling. International Medical Case Reports Journal. Volume 16. 659–665.
3.
Shiota, Seiji, et al.. (2022). Suspicion of pulmonary embolism after COVID-19 infection raised by a smartwatch. QJM. 116(2). 123–124. 1 indexed citations
4.
Shiota, Seiji, et al.. (2022). Esophageal achalasia: An unusual reason for lung abscess. Journal of General and Family Medicine. 23(3). 189–190. 2 indexed citations
6.
Shiota, Seiji, et al.. (2021). A case of community-onset Acinetobacter pneumonia in a healthy person. IDCases. 24. e01133–e01133. 2 indexed citations
7.
Shiota, Seiji, et al.. (2019). Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation. Case Reports in Medicine. 2019. 1–3. 5 indexed citations
8.
Ando, Masaru, Eishi Miyazaki, Yutaka Hatano, et al.. (2016). Subcutaneous sarcoidosis: a clinical analysis of nine patients. Clinical Rheumatology. 35(9). 2277–2281. 11 indexed citations
9.
Takenaka, Ryuichi, Shin‐ichi Nureki, Tamio Ueno, et al.. (2015). <i>Chromobacterium haemolyticum</i> Pneumonia Possibly Due to the Aspiration of Runoff Water. Japanese Journal of Infectious Diseases. 68(6). 526–529. 10 indexed citations
10.
Ando, Masaru, Hideaki Fujisaki, Mari Yamasue, et al.. (2012). Clinical Features of Sarcoidosis with Renal Insuficiency. 32(1). 101–105.
11.
Honda, Koichi, Fumito Okada, Yukio Ando, et al.. (2011). Comparison of pulmonary thin section CT findings and serum KL-6 levels in patients with sarcoidosis. British Journal of Radiology. 84(999). 229–235. 13 indexed citations
12.
Ono, Emiko, Haruhisa Mita, Masami Taniguchi, et al.. (2009). Concentration of 14,15‐leukotriene C4 (eoxin C4) in bronchoalveolar lavage fluid. Clinical & Experimental Allergy. 39(9). 1348–1352. 12 indexed citations
13.
Ando, Masaru, Takuya Ueno, Masahiro Hata, et al.. (2009). [A case of pulmonary sarcoidosis demonstrating panlobular ground-glass opacity with mosaic distribution].. PubMed. 47(3). 212–7. 1 indexed citations
14.
Ono, Emiko, Haruhisa Mita, Masami Taniguchi, et al.. (2008). Comparison of cysteinyl leukotriene concentrations between exhaled breath condensate and bronchoalveolar lavage fluid. Clinical & Experimental Allergy. 38(12). 1866–1874. 20 indexed citations
15.
Miyazaki, Eishi, Shin‐ichi Nureki, Masaru Ando, et al.. (2008). High-resolution computed tomography patterns and immunopathogenetic findings in drug-induced pneumonitis. Respiratory Medicine. 102(6). 892–898. 14 indexed citations
16.
Ono, Emiko, Yuji Maeda, Hidenori Tanimoto, et al.. (2007). [Clinical features of oral allergy syndrome to plant foods allergens in Kanto regions].. PubMed. 56(6). 587–92. 6 indexed citations
17.
Matsuno, Osamu, Toshiyuki Okubo, Emiko Ono, et al.. (2007). Drug-Induced Lymphocyte Stimulation Test is not Useful for the Diagnosis of Drug-Induced Pneumonia. The Tohoku Journal of Experimental Medicine. 212(1). 49–53. 30 indexed citations
18.
Miyazaki, Eishi, Shin‐ichi Nureki, Emiko Ono, et al.. (2007). Circulating Thymus- and Activation-Regulated Chemokine/CCL17 Is a Useful Biomarker for Discriminating Acute Eosinophilic Pneumonia From Other Causes of Acute Lung Injury. CHEST Journal. 131(6). 1726–1734. 24 indexed citations
19.
Miyazaki, Eishi, Shin‐ichi Nureki, Tetsujiro Fukami, et al.. (2002). Elevated Levels of Thymus- and Activation-regulated Chemokine in Bronchoalveolar Lavage Fluid from Patients with Eosinophilic Pneumonia. American Journal of Respiratory and Critical Care Medicine. 165(8). 1125–1131. 65 indexed citations
20.
Miyazaki, Eishi, et al.. (1995). A Case of Acute Eosinophilic Pneumonia Caused by Inhalation of Trichosporon Terrestre. American Journal of Respiratory and Critical Care Medicine. 151(2). 541–543. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026